Proceedings of the National Academy of Sciences · 2009 · 175 citations · 38 references
MedicineImmunologyOncologyCancer ImmunologyImmunoregulationMolecular OncologyAntitumor T Cell ResponsesCancer ImmunotherapyImmune Evasion In CancerMicrorna-mediated RegulationNoncoding Rna In CancerTumor-associated Antigens3' Untranslated Region RegulationCell LysisMicrorna Function In CancerMicrorna In CancerMicrorna In Immune RegulationMicrorna ModulationMicrorna Regulation In CancerMicrorna-mediated Immune Regulation
The RNase III endonuclease Dicer plays a key role in generation of microRNAs (miRs). We hypothesized that Dicer regulates cancer cell susceptibility to immune surveillance through miR processing. Indeed, Dicer disruption up-regulated intercellular cell adhesion molecule (ICAM)-1 and enhanced the susceptibility of tumor cells to antigen-specific lysis by cytotoxic T-lymphocytes (CTLs), while expression of other immunoregulatory proteins examined was not affected. Blockade of ICAM-1 inhibited the specific lysis of CTLs against Dicer-disrupted cells, indicating a pivotal role of ICAM-1 in the interaction between tumor cells and CTL. Both miR-222 and -339 are down-regulated in Dicer-disrupted cells and directly interacted with the 3' untranslated region (UTR) of ICAM-1 mRNA. Modulation of Dicer or these miRs inversely correlated with ICAM-1 protein expression and susceptibility of U87 glioma cells to CTL-mediated cytolysis while ICAM-1 mRNA levels remained stable. Immunohistochemical and in situ hybridization analyses of 30 primary glioblastoma tissues demonstrated that expression of Dicer, miR-222, or miR-339 was inversely associated with ICAM-1 expression. Taken together, Dicer is responsible for the generation of the mature miR-222 and -339, which suppress ICAM-1 expression on tumor cells, thereby down-regulating the susceptibility of tumor cells to CTL-mediated cytolysis. This study suggests development of novel miR-targeted therapy to promote cytolysis of tumor cells.
38
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
MicroRNA expression profiles classify human cancers
Jun Lü, Gad Getz, Eric A. Miska et al. · Nature · 2005 · 9.6K citations
MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing
Andrew Grimson, Kyle Kai‐How Farh, Wendy K. Johnston et al. · Molecular Cell · 2007 · 3.8K citations · Full text